Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ewing

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 22, 2007
Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the seriesBruce A Ellsworth, Ying Wang, Yeheng Zhu, et al.
Journal of Neurosurgery|June 5, 2026
Imaging, histological, and molecular characterization of a preclinical, orthotopic model of recurrent glioblastoma following image-guided laser ablation of the primary tumorTavarekere N Nagaraja, Seamus Bartlett, Glauber Cabral, et al.
Journal of Medicinal Chemistry|January 7, 2005
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokineticsNatesan Murugesan, Zhengxiang Gu, Leena Fadnis, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)Richard Sulsky, David R Magnin, Yanting Huang, et al.
Journal of Medicinal Chemistry|March 19, 2004
Discovery of a potent and novel motilin agonistJames J Li, Hann-Guang Chao, Haixia Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2017
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potencyJames R Corte, Wu Yang, Tianan Fang, et al.
Nature Metabolism|June 14, 2024
Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancerHyun Min Lee, Nefertiti Muhammad, Elizabeth L Lieu, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chainJun Li, Stephanie Y Chen, Shiwei Tao, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor XaW R Ewing, M R Becker, V E Manetta, et al.
Journal of Medicinal Chemistry|September 10, 1999
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimizationY M Choi-Sledeski, D G McGarry, D M Green, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|May 22, 2007
Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the seriesBruce A Ellsworth, Ying Wang, Yeheng Zhu, et al.
Journal of Neurosurgery|June 5, 2026
Imaging, histological, and molecular characterization of a preclinical, orthotopic model of recurrent glioblastoma following image-guided laser ablation of the primary tumorTavarekere N Nagaraja, Seamus Bartlett, Glauber Cabral, et al.
Journal of Medicinal Chemistry|January 7, 2005
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokineticsNatesan Murugesan, Zhengxiang Gu, Leena Fadnis, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2007
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)Richard Sulsky, David R Magnin, Yanting Huang, et al.
Journal of Medicinal Chemistry|March 19, 2004
Discovery of a potent and novel motilin agonistJames J Li, Hann-Guang Chao, Haixia Wang, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2017
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potencyJames R Corte, Wu Yang, Tianan Fang, et al.
Nature Metabolism|June 14, 2024
Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancerHyun Min Lee, Nefertiti Muhammad, Elizabeth L Lieu, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chainJun Li, Stephanie Y Chen, Shiwei Tao, et al.
Journal of Medicinal Chemistry|September 10, 1999
Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor XaW R Ewing, M R Becker, V E Manetta, et al.
Journal of Medicinal Chemistry|September 10, 1999
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimizationY M Choi-Sledeski, D G McGarry, D M Green, et al.
Pageof 28